Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathaniel Kleytman

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Molecular Genetics and Metabolism|July 31, 2019
Aberrant progranulin, YKL-40, cathepsin D and cathepsin S in Gaucher diseaseYuliya Afinogenova, Jiapeng Ruan, Ruhua Yang, et al.
Cureus|September 9, 2024
Gastric Rupture Secondary to a Heimlich Maneuver: A Case ReportNathaniel Kleytman, Savni Satoskar, Cesar Riera Gonzalez, et al.
Molecular Genetics and Metabolism Reports|September 6, 2021
Incremental biomarker and clinical outcomes after switch from enzyme therapy to eliglustat substrate reduction therapy in Gaucher diseaseNathaniel Kleytman, Jiapeng Ruan, Audrey Ruan, et al.
Elife|May 30, 2023
Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral centerMohsen Basiri, Mohammad E Ghaffari, Jiapeng Ruan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Molecular Genetics and Metabolism|July 31, 2019
Aberrant progranulin, YKL-40, cathepsin D and cathepsin S in Gaucher diseaseYuliya Afinogenova, Jiapeng Ruan, Ruhua Yang, et al.
Cureus|September 9, 2024
Gastric Rupture Secondary to a Heimlich Maneuver: A Case ReportNathaniel Kleytman, Savni Satoskar, Cesar Riera Gonzalez, et al.
Molecular Genetics and Metabolism Reports|September 6, 2021
Incremental biomarker and clinical outcomes after switch from enzyme therapy to eliglustat substrate reduction therapy in Gaucher diseaseNathaniel Kleytman, Jiapeng Ruan, Audrey Ruan, et al.
Elife|May 30, 2023
Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral centerMohsen Basiri, Mohammad E Ghaffari, Jiapeng Ruan, et al.
Pageof 1